Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of Immunology Research|November 6, 2015
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma PatientsShigeru Yutani, Kazuomi Ueshima, Kazumichi Abe, et al.
Experimental and Therapeutic Medicine|April 18, 2017
Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy femalesMasato Yokomine, Satoko Matsueda, Kouichiro Kawano, et al.
Human Vaccines & Immunotherapeutics|September 2, 2015
Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccinationShinjiro Sakamoto, Munehiro Yoshitomi, Shigeru Yutani, et al.
Experimental Dermatology|May 16, 2014
Human dermal fibroblast migration induced by fibronectin in autocrine and paracrine mannersXiaoguang Li, Hua Qian, Fumitake Ono, et al.
Cancer|November 11, 2011
Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccinationNobukazu Komatsu, Satoko Matsueda, Kousuke Tashiro, et al.
Clinical Lung Cancer|April 19, 2017
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung CancerShinjiro Sakamoto, Teppei Yamada, Yasuhiro Terazaki, et al.
Plos One|October 3, 2012
Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapySatoko Matsueda, Mingjun Wang, Jinsheng Weng, et al.
Cancer Science|February 11, 2012
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancerYasuhiro Terazaki, Koichi Yoshiyama, Satoko Matsueda, et al.
Plos One|November 14, 2013
EGFR T790M mutation as a possible target for immunotherapy; identification of HLA-A*0201-restricted T cell epitopes derived from the EGFR T790M mutationTeppei Yamada, Koichi Azuma, Emi Muta, et al.
International Journal of Oncology|October 14, 2014
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimensTeppei Yamada, Yasuhiro Terazaki, Shinjiro Sakamoto, et al.
Pageof 9